Hall Jeffrey

SEC source: 0000791519-17-000125 · wf-form4_150524721003907.xml · nonDerivative · entry 1

Hall Jeffrey · CIK 0001299172 · Vice Chairman & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Pursuant to the Agreement and Plan of Merger dated as of June 28, 2017 among issuer, Arch Parent Inc. and Arch Merger Sub Inc. (the "Merger Agreement"), pursuant to which Arch Merger Sub Inc. merged with and into the issuer (the "Merger") effective as of September 12, 2017, restricted stock units outstanding immediately prior to the effective time of the Merger were canceled and converted into the contingent right to receive an amount in cash equal to $10.25 per underlying share on the earlier of (i) the date on which the original vesting conditions applicable to the award (taking into account any accelerated vesting provisions to which the award is subject) are satisfied or (ii) 180 days following the closing date, subject, in each case, to the reporting person's continuous service to the issuer through the applicable vesting date.

SEC source: 0000791519-17-000029 · wf-form4_148909526470938.xml · nonDerivative · entry 1

Hall Jeffrey · CIK 0001299172 · Vice Chairman & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,859

F1 · shares: Restricted Stock Unit vesting as follows: 1/3 vests on March 8, 2018; 1/3 vests on March 8, 2019; 1/3 vests on March 8, 2020.

SEC source: 0001628280-16-021894 · wf-form4_148122535718781.xml · derivative · entry 7

Hall Jeffrey · CIK 0001299172 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 143,000 shares

Expires 2026-04-01

F7 · price: This option was scheduled to vest in four equal annual installments commencing on April 1, 2017.

F7 · derivative.exercise_date: This option was scheduled to vest in four equal annual installments commencing on April 1, 2017.

SEC source: 0001628280-16-021894 · wf-form4_148122535718781.xml · derivative · entry 6

Hall Jeffrey · CIK 0001299172 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 6,863 shares

Expires not disclosed

F2 · derivative.exercise_price: Restricted stock units ("RSUs") granted under the Company's 2014 Non-Employee Director Incentive Plan. Each RSU represented a contingent right to receive an ordinary share of the Company.

F6 · derivative.exercise_date: The RSUs were granted on June 13, 2014 and were scheduled to vest in equal installments on the third and fourth anniversary of the date of grant. Pursuant to the Implementation Agreement, these RSUs became vested in their entirety and converted into the right to receive a cash payment equal to $12.00 per share covered by the RSU.

F6 · derivative.expiration_date: The RSUs were granted on June 13, 2014 and were scheduled to vest in equal installments on the third and fourth anniversary of the date of grant. Pursuant to the Implementation Agreement, these RSUs became vested in their entirety and converted into the right to receive a cash payment equal to $12.00 per share covered by the RSU.

SEC source: 0001628280-16-021894 · wf-form4_148122535718781.xml · derivative · entry 5

Hall Jeffrey · CIK 0001299172 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 3,432 shares

Expires not disclosed

F2 · derivative.exercise_price: Restricted stock units ("RSUs") granted under the Company's 2014 Non-Employee Director Incentive Plan. Each RSU represented a contingent right to receive an ordinary share of the Company.

F6 · derivative.exercise_date: The RSUs were granted on June 13, 2014 and were scheduled to vest in equal installments on the third and fourth anniversary of the date of grant. Pursuant to the Implementation Agreement, these RSUs became vested in their entirety and converted into the right to receive a cash payment equal to $12.00 per share covered by the RSU.

F6 · derivative.expiration_date: The RSUs were granted on June 13, 2014 and were scheduled to vest in equal installments on the third and fourth anniversary of the date of grant. Pursuant to the Implementation Agreement, these RSUs became vested in their entirety and converted into the right to receive a cash payment equal to $12.00 per share covered by the RSU.

SEC source: 0001628280-16-021894 · wf-form4_148122535718781.xml · derivative · entry 4

Hall Jeffrey · CIK 0001299172 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 11,485 shares

Expires not disclosed

F2 · derivative.exercise_price: Restricted stock units ("RSUs") granted under the Company's 2014 Non-Employee Director Incentive Plan. Each RSU represented a contingent right to receive an ordinary share of the Company.

F5 · derivative.exercise_date: The RSUs were granted on June 11, 2015 and were scheduled to vest in equal installments on the second, third and fourth anniversary of the date of grant. Pursuant to the Implementation Agreement, these RSUs became vested in their entirety and converted into the right to receive a cash payment equal to $12.00 per share covered by the RSU

F5 · derivative.expiration_date: The RSUs were granted on June 11, 2015 and were scheduled to vest in equal installments on the second, third and fourth anniversary of the date of grant. Pursuant to the Implementation Agreement, these RSUs became vested in their entirety and converted into the right to receive a cash payment equal to $12.00 per share covered by the RSU

SEC source: 0001628280-16-021894 · wf-form4_148122535718781.xml · derivative · entry 3

Hall Jeffrey · CIK 0001299172 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 27,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Restricted stock units ("RSUs") granted under the Company's 2014 Non-Employee Director Incentive Plan. Each RSU represented a contingent right to receive an ordinary share of the Company.

F4 · derivative.exercise_date: The RSUs were granted on April 1, 2016 and were scheduled to vest in four equal installments commencing on the first anniversary of the date of grant. Pursuant to the Implementation Agreement, these RSUs became vested in their entirety and converted into the right to receive a cash payment equal to $12.00 per share covered by the RSU.

F4 · derivative.expiration_date: The RSUs were granted on April 1, 2016 and were scheduled to vest in four equal installments commencing on the first anniversary of the date of grant. Pursuant to the Implementation Agreement, these RSUs became vested in their entirety and converted into the right to receive a cash payment equal to $12.00 per share covered by the RSU.

SEC source: 0001628280-16-021894 · wf-form4_148122535718781.xml · derivative · entry 2

Hall Jeffrey · CIK 0001299172 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 57,692 shares

Expires not disclosed

F2 · derivative.exercise_price: Restricted stock units ("RSUs") granted under the Company's 2014 Non-Employee Director Incentive Plan. Each RSU represented a contingent right to receive an ordinary share of the Company.

F3 · derivative.exercise_date: The RSUs were granted on May 28, 2014, and would have vested in full upon achievement of a performance criteria. Pursuant to the Implementation Agreement, these RSUs became vested in their entirety and converted into the right to receive a cash payment equal to $12.00 per share covered by the RSU, assuming achievement of the performance goal at 100% of target level.

F3 · derivative.expiration_date: The RSUs were granted on May 28, 2014, and would have vested in full upon achievement of a performance criteria. Pursuant to the Implementation Agreement, these RSUs became vested in their entirety and converted into the right to receive a cash payment equal to $12.00 per share covered by the RSU, assuming achievement of the performance goal at 100% of target level.

SEC source: 0001628280-16-021894 · wf-form4_148122535718781.xml · nonDerivative · entry 1

Hall Jeffrey · CIK 0001299172 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Pursuant to the Implementation Agreement (the "Implementation Agreement"), dated as of August 17, 2016, by and among SunEdison Semiconductor Limited (the "Company"), GlobalWafers Co., Ltd. ("GWC") and GWafers Singapore Pte. Ltd. ("Acquiror") and Scheme of Arrangement under Singapore law, Acquiror acquired all of the outstanding ordinary shares of the Company (including those of Mr. Sadasivam, but excluding those held by GWC, Acuiror and their subsidiaries) in exchange for a cash payment of $12.00 per share on December 2, 2016.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 12

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,896

Underlying: Common Stock · 1,896 shares

Expires 2012-11-08

F12 · kind: On November 8, 2002, the reporting person was granted an option to purchase 3,250 shares of the Issuer's Common Stock at a purchase price of $37.05 per share. The actual grant date was subsequently determined to be November 18, 2002. Had the option been granted at fair market value on November 18, 2002, the exercise price of the option would have been $37.43 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,896 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($37.43) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 13)

F13 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 1,354 shares at the original exercise price of $37.05 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F12 · price: On November 8, 2002, the reporting person was granted an option to purchase 3,250 shares of the Issuer's Common Stock at a purchase price of $37.05 per share. The actual grant date was subsequently determined to be November 18, 2002. Had the option been granted at fair market value on November 18, 2002, the exercise price of the option would have been $37.43 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,896 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($37.43) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 13)

F13 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 1,354 shares at the original exercise price of $37.05 per share.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 11

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,896 shares

Expires 2012-11-08

F12 · kind: On November 8, 2002, the reporting person was granted an option to purchase 3,250 shares of the Issuer's Common Stock at a purchase price of $37.05 per share. The actual grant date was subsequently determined to be November 18, 2002. Had the option been granted at fair market value on November 18, 2002, the exercise price of the option would have been $37.43 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,896 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($37.43) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 13)

F13 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 1,354 shares at the original exercise price of $37.05 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F12 · price: On November 8, 2002, the reporting person was granted an option to purchase 3,250 shares of the Issuer's Common Stock at a purchase price of $37.05 per share. The actual grant date was subsequently determined to be November 18, 2002. Had the option been granted at fair market value on November 18, 2002, the exercise price of the option would have been $37.43 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,896 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($37.43) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 13)

F13 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 1,354 shares at the original exercise price of $37.05 per share.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 10

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,700

Underlying: Common Stock · 7,700 shares

Expires 2011-10-02

F10 · kind: On October 2, 2001, the reporting person was granted an option to purchase 21,000 shares of the Issuer's Common Stock at a purchase price of $29.31 per share. The actual grant date was subsequently determined to be October 25, 2001. Had the option been granted at fair market value on October 25, 2001, the exercise price of the option would have been $45.25 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 7,700 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($45.25) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 11)

F11 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 800 shares at the original exercise price of $29.31 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F10 · price: On October 2, 2001, the reporting person was granted an option to purchase 21,000 shares of the Issuer's Common Stock at a purchase price of $29.31 per share. The actual grant date was subsequently determined to be October 25, 2001. Had the option been granted at fair market value on October 25, 2001, the exercise price of the option would have been $45.25 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 7,700 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($45.25) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 11)

F11 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 800 shares at the original exercise price of $29.31 per share.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 9

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,700 shares

Expires 2011-10-02

F10 · kind: On October 2, 2001, the reporting person was granted an option to purchase 21,000 shares of the Issuer's Common Stock at a purchase price of $29.31 per share. The actual grant date was subsequently determined to be October 25, 2001. Had the option been granted at fair market value on October 25, 2001, the exercise price of the option would have been $45.25 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 7,700 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($45.25) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 11)

F11 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 800 shares at the original exercise price of $29.31 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F10 · price: On October 2, 2001, the reporting person was granted an option to purchase 21,000 shares of the Issuer's Common Stock at a purchase price of $29.31 per share. The actual grant date was subsequently determined to be October 25, 2001. Had the option been granted at fair market value on October 25, 2001, the exercise price of the option would have been $45.25 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 7,700 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($45.25) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 11)

F11 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 800 shares at the original exercise price of $29.31 per share.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 8

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,700

Underlying: Common Stock · 1,700 shares

Expires 2011-10-02

F9 · kind: On October 2, 2001, the reporting person was granted an option to purchase 6,000 shares of the Issuer's Common Stock at a purchase price of $29.31 per share. The actual grant date was subsequently determined to be October 24, 2001. Had the option been granted at fair market value on October 24, 2001, the exercise price of the option would have been $40.86 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($40.86) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). The amendment is reported in this Form 4 as a cancellation of the option and the grant of a replacement option.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F9 · price: On October 2, 2001, the reporting person was granted an option to purchase 6,000 shares of the Issuer's Common Stock at a purchase price of $29.31 per share. The actual grant date was subsequently determined to be October 24, 2001. Had the option been granted at fair market value on October 24, 2001, the exercise price of the option would have been $40.86 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($40.86) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). The amendment is reported in this Form 4 as a cancellation of the option and the grant of a replacement option.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 7

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,700 shares

Expires 2011-10-02

F9 · kind: On October 2, 2001, the reporting person was granted an option to purchase 6,000 shares of the Issuer's Common Stock at a purchase price of $29.31 per share. The actual grant date was subsequently determined to be October 24, 2001. Had the option been granted at fair market value on October 24, 2001, the exercise price of the option would have been $40.86 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($40.86) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). The amendment is reported in this Form 4 as a cancellation of the option and the grant of a replacement option.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F9 · price: On October 2, 2001, the reporting person was granted an option to purchase 6,000 shares of the Issuer's Common Stock at a purchase price of $29.31 per share. The actual grant date was subsequently determined to be October 24, 2001. Had the option been granted at fair market value on October 24, 2001, the exercise price of the option would have been $40.86 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($40.86) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). The amendment is reported in this Form 4 as a cancellation of the option and the grant of a replacement option.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 6

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 625

Underlying: Common Stock · 625 shares

Expires 2011-07-10

F7 · kind: On July 10, 2001, the reporting person was granted an option to purchase 6,000 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 625 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 8)

F8 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 5,375 shares at the original exercise price of $46.67 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F7 · price: On July 10, 2001, the reporting person was granted an option to purchase 6,000 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 625 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 8)

F8 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 5,375 shares at the original exercise price of $46.67 per share.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 5

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 625 shares

Expires 2011-07-10

F7 · kind: On July 10, 2001, the reporting person was granted an option to purchase 6,000 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 625 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 8)

F8 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 5,375 shares at the original exercise price of $46.67 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F7 · price: On July 10, 2001, the reporting person was granted an option to purchase 6,000 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 625 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 8)

F8 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 5,375 shares at the original exercise price of $46.67 per share.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 4

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,046

Underlying: Common Stock · 1,046 shares

Expires 2011-07-10

F5 · kind: On July 10, 2001, the reporting person was granted an option to purchase 5,703 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,046 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 6)

F6 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 1,657 shares at the original exercise price of $46.67 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F5 · price: On July 10, 2001, the reporting person was granted an option to purchase 5,703 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,046 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 6)

F6 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 1,657 shares at the original exercise price of $46.67 per share.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 3

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,046 shares

Expires 2011-07-10

F5 · kind: On July 10, 2001, the reporting person was granted an option to purchase 5,703 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,046 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 6)

F6 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 1,657 shares at the original exercise price of $46.67 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F5 · price: On July 10, 2001, the reporting person was granted an option to purchase 5,703 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,046 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51). (Continue with footnote 6)

F6 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 1,657 shares at the original exercise price of $46.67 per share.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 2

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,521

Underlying: Common Stock · 1,521 shares

Expires 2011-07-10

F1 · kind: On July 10, 2001, the reporting person was granted an option to purchase 5,703 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,521 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51).(Continue with footnote 2)

F2 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 4,182 shares at the original exercise price of $46.67 per share.

F1 · price: On July 10, 2001, the reporting person was granted an option to purchase 5,703 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,521 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51).(Continue with footnote 2)

F2 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 4,182 shares at the original exercise price of $46.67 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-067768 · rrd177876.xml · derivative · entry 1

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,521 shares

Expires 2011-07-10

F1 · kind: On July 10, 2001, the reporting person was granted an option to purchase 5,703 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,521 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51).(Continue with footnote 2)

F2 · kind: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 4,182 shares at the original exercise price of $46.67 per share.

F1 · price: On July 10, 2001, the reporting person was granted an option to purchase 5,703 shares of the Issuer's Common Stock at a purchase price of $46.67 per share. The actual grant date was subsequently determined to be August 7, 2001. Had the option been granted at fair market value on August 7, 2001, the exercise price of the option would have been $54.57 per share. To avoid adverse tax consequences, the Compensation Committee of the Board of Directors of the Issuer approved an amendment to the stock option on November 6, 2007 to increase the exercise price, with respect to the portion of the option vesting after December 31, 2004 (representing 1,521 shares), to the lower of (a) the fair market value per share of the Issuer's common stock on the actual grant date ($54.57) or (b) the fair market value per share on the November 6, 2007 amendment date ($50.51).(Continue with footnote 2)

F2 · price: The amendment is reported in this Form 4 as a cancellation of a portion of the option and the grant of a replacement option. The option remains exercisable for 4,182 shares at the original exercise price of $46.67 per share.

F4 · price: In connection with the amendments described in this Form 4, the reporting person became entitled to receive, in January 2008, a cash payment of $155,350.76, which is the aggregate amount of the increases in the exercise prices of the options described in this Form 4.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

SEC source: 0001181431-07-051766 · rrd169139.xml · nonDerivative · entry 1

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,750

F1 · security: On September 19, 2006, the Reporting Person was granted a restricted stock unit covering up to 18,750 shares of the Issuer's Common Stock which are subject to both performance-vesting and service-vesting requirements. Following the completion of the Issuer's audited financial statements for the 2007 fiscal year, the Issuer's Board of Directors determined on August 8, 2007 the level at which the performance goals were attained, and based on that assessment, determined that the number of shares subject to the restricted stock units is 18,750. The Reporting Person will vest in 50% of the restricted stock units upon his completion of two years of service with the Issuer measured from September 19, 2006 and will vest in the remaining 50% upon his completion of an additional two years of service thereafter. The shares of common stock will be issued as the restricted stock units vest.

F1 · shares: On September 19, 2006, the Reporting Person was granted a restricted stock unit covering up to 18,750 shares of the Issuer's Common Stock which are subject to both performance-vesting and service-vesting requirements. Following the completion of the Issuer's audited financial statements for the 2007 fiscal year, the Issuer's Board of Directors determined on August 8, 2007 the level at which the performance goals were attained, and based on that assessment, determined that the number of shares subject to the restricted stock units is 18,750. The Reporting Person will vest in 50% of the restricted stock units upon his completion of two years of service with the Issuer measured from September 19, 2006 and will vest in the remaining 50% upon his completion of an additional two years of service thereafter. The shares of common stock will be issued as the restricted stock units vest.

SEC source: 0000319201-06-000021 · edgardoc.xml · derivative · entry 3

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2013-02-17

SEC source: 0000319201-06-000021 · edgardoc.xml · nonDerivative · entry 1

Hall Jeffrey · CIK 0001299172 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

F1 · security: Each restricted stock unit represents a contingent right to receive one share of KLAC common stock.

F2 · price: The restricted stock units vest in two equal installments. The first half vests four years from grant date. The second half vests one year thereafter.

SEC source: 0000319201-05-000167 · edgardoc.xml · derivative · entry 4

Hall Jeffrey · CIK 0001299172 · VP, Corporate Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,200

Underlying: Common Stock · 4,000 shares

Expires 2011-10-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000319201-05-000167 · edgardoc.xml · nonDerivative · entry 2

Hall Jeffrey · CIK 0001299172 · VP, Corporate Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,791

SEC source: 0000319201-05-000167 · edgardoc.xml · nonDerivative · entry 1

Hall Jeffrey · CIK 0001299172 · VP, Corporate Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,791

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000319201-05-000138 · edgardoc.xml · derivative · entry 3

Hall Jeffrey · CIK 0001299172 · VP, Corporate Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2012-09-26

SEC source: 0000319201-05-000109 · edgardoc.xml · derivative · entry 4

Hall Jeffrey · CIK 0001299172 · VP, Corporate Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,200

Underlying: Common Stock · 3,000 shares

Expires 2011-10-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000319201-05-000109 · edgardoc.xml · nonDerivative · entry 2

Hall Jeffrey · CIK 0001299172 · VP, Corporate Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,791

SEC source: 0000319201-05-000109 · edgardoc.xml · nonDerivative · entry 1

Hall Jeffrey · CIK 0001299172 · VP, Corporate Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,791

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000319201-05-000048 · edgardoc.xml · derivative · entry 4

Hall Jeffrey · CIK 0001299172 · VP, Corporate Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,200

Underlying: Common Stock · 2,300 shares

Expires 2011-10-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000319201-05-000048 · edgardoc.xml · nonDerivative · entry 2

Hall Jeffrey · CIK 0001299172 · VP, Corporate Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,367

SEC source: 0000319201-05-000048 · edgardoc.xml · nonDerivative · entry 1

Hall Jeffrey · CIK 0001299172 · VP, Corporate Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,667

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000319201-05-000044 · edgardoc.xml · nonDerivative · entry 1

Hall Jeffrey · CIK 0001299172 · VP, Corporate Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

F1 · security: Each restricted stock unit represents a contingent right to receive one share of KLAC common stock.

F2 · price: The restricted stock units vest in two equal installments. The first half vests four years from grant date. The second half vests one year thereafter.

SEC source: 0000319201-04-000178 · edgardoc.xml · derivative · entry 3

Hall Jeffrey · CIK 0001299172 · VP, Corporate Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,500

Underlying: Common Stock · 3,000 shares

Expires 2011-10-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000319201-04-000178 · edgardoc.xml · nonDerivative · entry 2

Hall Jeffrey · CIK 0001299172 · VP, Corporate Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 981

SEC source: 0000319201-04-000178 · edgardoc.xml · nonDerivative · entry 1

Hall Jeffrey · CIK 0001299172 · VP, Corporate Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,981

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000319201-04-000124 · edgardoc.xml · derivative · entry 2

Hall Jeffrey · CIK 0001299172 · VP, Corporate Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2014-09-21

SEC source: 0000319201-04-000084 · edgardoc.xml · derivative · entry 2

Hall Jeffrey · CIK 0001299172 · VP, Corporate Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,950

Underlying: Common Stock · 1,950 shares

Expires 2014-08-02

F1 · shares: Form filings are completed by the Company on behalf of the officer listed. Due to an administrative error, this grant of options is being reported late.